Introduction
Completion of the human genome project has greatly increased the discovery of functional and disease-related genes. Gene therapy has become one of the most active research areas in biomedicine in the 21st century. One of the main advantages of gene therapy over traditional therapy is the potential to target the expression of therapeutic genes in desired cells or tissues. To achieve targeted gene expression, we developed a novel nonviral gene delivery system.
Arsenic trioxide (As 2 O 3 ) has been adopted from traditional Chinese medicine and used successfully to treat refractory or relapsed acute promyelocytic leukemia. 1 In recent years, some researchers have found that As 2 O 3 was not only effective in leukemia treatment, but also effective in inhibiting several animal and human solid cancers, such as neuroblastoma, liver, and gastric cancers. [2] [3] [4] However, there is a lack of drug specificity with the intravenous or oral administration of As 2 O 3 , resulting in the requirement of large doses to achieve high local concentrations. This can cause nonspecific toxicity and other adverse side effects. Moreover, As 2 O 3 has been generally considered to be an extremely effective environmental cocarcinogen for some human malignancies, especially for renal, skin, and lung cancer.
5-7 Therefore, we investigated an alternative means of administering As 2 O 3 to enhance its curative effects and reduce toxicity.
Clinically, the use of thermotherapy, such as heating certain organs or tissues to temperatures between 41°C and 46°C, also known as hyperthermia, has been longused in the treatment of tumors. With the development of nanotechnology, magnetic nanoparticles have been used for tumor hyperthermia, to absorb energy from an applied high frequency alternating magnetic field (AMF). This treatment is known as magnetic fluid hyperthermia (MFH). 8 MFH is more effective in the uniform heating of deeplysituated tumors, with relatively good targeting. Generally, in this technique, magnetic fluids are dispersed into the target tissue, which are then heated through the application of an external AMF. 9 In this paper, we aimed to develop a novel nanosized magnetic liposome containing the PEI-As 2 
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Methods
Preparation of MZF and PeI-As 2 O 3 / MZF nanoparticles MZF nanoparticles were prepared using chemical coprecipitation. They were examined by transmission electron microscopy (TEM) (H-600; Hitachi, Tokyo, Japan) and scanning electron microscopy (SEM) (JSM-6360LV; Jeol, Tokyo, Japan). The element composition and content of the nanoparticles were analyzed by X-ray diffraction (XRD) and energy dispersive spectrometry (EDS) (Vantage; Thermo Noran, Middleton, WI). MZF was subsequently modified by As 2 O 3 and adsorbed by PEI, according to a previouslydescribed method. The adsorption efficiency of PEI was demonstrated by Fourier transform infrared spectroscopy (FTIR) (560; Thermo Nicolet, Madison, WI) and EDS.
cell transfection
Prior to transfection, pGFP plasmid DNA and PEI-As 2 O 3 / MZF nanoparticles were diluted separately in serum-and supplement-free medium. Subsequently, 6 µg plasmid DNA per well was complexed with various amounts of PEIAs 2 O 3 /MZF-NPs (10 mg/mL), corresponding to a nitrogen/ phosphorus (N/P) ratio of particles to DNA in a final volume of 400 µL serum-and supplement-free medium. The complexes were then incubated at room temperature for 30 minutes. As a reference, 10 PEI (complexed with DNA at an N/P ratio of 7) or commercially-available transfection reagents, such as Lipofectamine™ (Invitrogen, Carlsbad, CA) were used in accordance with the manufacturer's instructions.
HepG-2 cells were seeded in six well plates, at an initial density of 2 × 10 5 cells/well in 2 mL growth medium. After incubation for 18 hours, when cells had reached 80% confluency, the medium was replaced with 1.6 mL serum-free media and 400 µL PEI-As 2 O 3 /MZF-NPs/pGFP complexes, followed by a further incubation for 4 hours. The medium was then exchanged for fresh medium containing serum 200 nm 
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Preparation of nanocomplexes and incubated further. Cells were observed using inverted fluorescence microscopy at 24 hours and 48 hours posttransfection, to evaluate transfection efficiency.
Preparation of nanoliposomes, containing PeI-As 2 O 3 /MZF and heating tests Results and discussion characterization of MZF and PeI-As 2 O 3 / MZF nanoparticles MZF nanoparticles were evaluated by TEM, XRD, and EDS. Using TEM, MZF particles appeared round or elliptical in shape, with good dispersion and were 20-30 nm in diameter (Figure 1) Figure 4 ). Further cell transfection experiments suggested that PEI-As 2 O 3 /MZF nanoparticles were efficient carriers for gene transfection. The observed green cellular fluorescence was due to pGFP expression, which was confirmed by inverted fluorescence microscopy 24 hours post-transfection. The expression of GFP was much clearer at 48 hours post-transfection ( Figure 5 ). This high transfer efficiency was due to the inherent proton absorption properties of PEI. 11 However, the use of PEI as a gene carrier is limited by cytotoxicity and nonspecific interactions with serum proteins. In our study, we used nanoliposomes to engulf the PEI-As 2 O 3 /MZF complexes and reduce their toxic side effects, which has not been previously reported.
Properties of nanoliposomes containing PeI-As 2 O 3 /MZF
We prepared magnetic nanoliposomes containing PEIAs 2 O 3 /MZF complexes, with an average diameter of approximately 100 nm. The encapsulation ratio of As 2 O 3 was analyzed by fluorescence spectrophotometry and determined to be 75.33%. An in vitro heating test was performed to detect the thermodynamic characteristics of the nanoliposomes. The temperature of the nanoliposomes exposed to AMF rose rapidly within the first 5 minutes and slowly continued to increase from 5-40 minutes, remaining stable thereafter. The temperature rose from 37°C to 54°C, depending on various doses of PEI-As 2 O 3 /MZF ( Figure 6 ). The results showed that nanoliposomes had good absorption properties in high-frequency alternating electromagnetic fields, due to the presence of magnetic nanoparticles. The modified PEI, As 2 O 3 , and lipid membrane did not influence the magnetic responsiveness of MZF. Therefore, we can select a suitable temperature range (42°C-46°C) for tumor hyperthermia by adjusting the concentration of PEI-As 2 O 3 /MZF. 
International Journal of Nanomedicine
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/international-journal-of-nanomedicine-journal
The International Journal of Nanomedicine is an international, peerreviewed journal focusing on the application of nanotechnology in diagnostics, therapeutics, and drug delivery systems throughout the biomedical field. This journal is indexed on PubMed Central, MedLine, CAS, SciSearch®, Current Contents®/Clinical Medicine, Journal Citation Reports/Science Edition, EMBase, Scopus and the Elsevier Bibliographic databases. The manuscript management system is completely online and includes a very quick and fair peer-review system, which is all easy to use. Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors. 
Conclusion
Nanotechnology has been increasingly applied in the medical field, with potential treatments for cancer. In our study, we prepared a new kind of magnetic nanoliposome containing PEI-As 2 O 3 /MZF complexes. It has multiple antitumor applications, including thermotherapy using magnetic MZF nanoparticles, gene therapy with PEI-modified complexes, and chemotherapy using As 2 O 3 . In future studies, we will apply this novel material to tumor therapy.
